Federal contract award
15B41825F00000127
MEDICATION USED TO TREAT PULMONARY HYPERTENSION FOR INMATE POPULATION.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Justice |
| Office | USP TERRE HAUTE |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 36F79724D0159 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $35.4K |
| Current contract value | $35.4K |
| Potential contract value / ceiling | $35.4K |
| Start date | Feb 12, 2025 |
| Current end date | Feb 17, 2025 |
| Potential end date | Mar 4, 2025 |
| Latest award activity | Mar 4, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 4, 2025 | P00001 | $-11 | MEDICATION USED TO TREAT PULMONARY HYPERTENSION FOR INMATE POPULATION. |
| Feb 12, 2025 | 0 | $35.4K | MEDICATION USED TO TREAT PULMONARY HYPERTENSION FOR INMATE POPULATION. |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.